EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma

Panpan Li iD, Bei Xu, Jiadai Xu, Yanyan Xu, Yawen Wang, Chen Chen, Peng Liu

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241814097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Panpan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Hauptthemen laut MEDLINE: Lenalidomide, Multiple Myeloma, Platelet Activation, Thrombosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peng Liu, Jiadai Xu, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lenalidomide, a well-established drug for the treatment of multiple myeloma, significantly enhances patients’ survival. Previous clinical studies have demonstrated that its main side effect is an increased risk of thrombotic events. However, the underlying mechanism remains unexplored. Therefore, this study aims to elucidate the mechanism and offer insights into the selection of clinical thrombotic prophylaxis drugs. Firstly, we conducted a retrospective analysis of clinical data from 169 newly diagnosed multiple myeloma patients who received lenalidomide. To confirm the impact of lenalidomide on thrombosis formation, FeCl3-induced thrombosis and deep venous thrombosis models in mice were established. To investigate the effects of lenalidomide on platelet function, both in vivo and in vitro experiments were designed. During the follow-up period, 8 patients developed thrombotic events, including 8 venous and 1 arterial. Further investigation using mice models demonstrated that lenalidomide significantly promoted the formation of venous thrombosis, consistent with clinical findings. To elucidate the underlying mechanism, assays were conducted to assess platelet function and coagulation. We observed that lenalidomide did not have any noticeable impact on platelet function, both in vitro and in vivo, while administration of lenalidomide resulted in significant decreases in prothrombin time, thrombin time, and prothrombin time ratio in patients, as well as a remarkable reduction in tail-bleeding time in mice. The administration of lenalidomide had no significant impact on platelet function, which may affect venous thrombus formation by affecting coagulation. Therefore, anticoagulant drugs may be superior to antiplatelet drugs in the selection of clinical thrombus prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LenalidomideMultiple MyelomaPlatelet ActivationThrombosisAnimalsMiceHumansMaleFemaleMiddle AgedAgedRetrospective StudiesVenous ThrombosisBlood CoagulationDisease Models, AnimalBlood Platelets

Stichwörter der Autor:innen

immunomodulatory drugsmultiple myelomaplateletthrombosis

Substanzen

Lenalidomide

Autor:innen und Institutionen

  • Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China.

ORCID-Profile: Panpan Li

Förderung

  • Peng Liu
  • Jiadai Xu
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Natural Science Foundation of Fujian province

Zitieren

APA

Li, P., Xu, B., Xu, J., Xu, Y., Wang, Y., Chen, C., & Liu, P. (2023). Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814097

Vancouver

Li P, Xu B, Xu J, Xu Y, Wang Y, Chen C, et al. Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814097

BibTeX
@article{Li2023,
  author = {Li, Panpan and Xu, Bei and Xu, Jiadai and Xu, Yanyan and Wang, Yawen and Chen, Chen and Liu, Peng},
  title = {Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241814097}
}
Kostenlos starten →